No association was found between taking the supplements and a lower risk of major cardiovascular events (heart attack, stroke, or death from cardiovascular causes) compared with the placebo. The VITamin D and OmegA-3 TriaL (VITAL) came to the same conclusion; it followed 25,871 men and women free of cardiovascular disease who took either a 2,000 IU vitamin D supplement or placebo daily for a median of five years. In the Health Professionals Follow-up Study nearly 50,000 healthy men were followed for 10 years. The heart is basically a large muscle, and like skeletal muscle, it has receptors for vitamin D. These findings are consistent with observational data, which suggest that vitamin D may have a stronger effect on cancer progression than for incidence. In the VITAL trial, a lower death rate from cancer was observed in those assigned to take vitamin D, and this benefit seemed to increase over time since starting on vitamin D. Although vitamin D does not seem to be a major factor in reducing cancer incidence, evidence including that from randomized trials suggests that having higher vitamin D status may improve survival if one develops cancer.
Understanding the factors that influence TRT’s effects on inflammation can help patients and healthcare providers make informed decisions. It holds promise for reducing harmful inflammation and improving heart health in men with low testosterone levels. Some studies suggest that TRT may help reduce inflammation in the cardiovascular system, particularly in men with low testosterone levels.
Testosterone plays a role in regulating inflammation, but when you use TRT over many years, the effects can vary. TRT holds promise as a tool to reduce inflammation and improve metabolic health. These conditions are often linked to chronic, low-grade inflammation. Testosterone Replacement Therapy (TRT) is increasingly studied for its potential to reduce inflammation and improve metabolic health. For the best outcomes, patients should work closely with a knowledgeable healthcare provider to create a personalized treatment plan. Inflammation can damage this lining, but testosterone has been shown to improve endothelial function in some men, further supporting heart health.
The authors noted that a longer follow-up period would be necessary to better assess potential effects of supplementation, as many cancers take at least 5-10 years to develop. The findings did not show significantly different rates of breast, prostate, and colorectal cancer between the vitamin D and placebo groups. 4) seven years may be too short to expect a reduction in cancer risk. These studies can be a good starting point for other research but don’t provide the most definitive information. The role of vitamin D in disease prevention is a popular area of research, but clear answers about the benefit of taking amounts beyond the RDA are not conclusive.
Testosterone Replacement Therapy (TRT) has shown promise in reducing inflammation for some people, but it is important to remember that it is not risk-free. It’s crucial for anyone considering TRT to consult a doctor and undergo proper testing to ensure their inflammation levels are accurately assessed. Testosterone interacts with cells in the immune system, directly influencing how they respond to inflammation.
Testosterone, one of the primary male hormones, plays a significant role in modulating the immune system. These conditions often involve chronic inflammation as a core feature. Autoimmune diseases occur when the body’s immune system mistakenly attacks its own tissues. The risks are higher for people with pre-existing health problems, improper dosing, or lack of medical supervision. TRT may worsen inflammation in people with certain pre-existing conditions. However, testosterone may also activate inflammatory pathways under certain circumstances.
Half of the study participants received pills that contained 1,200 IU of vitamin D; the other half received placebo pills. And could vitamin D supplements help boost our body’s defenses to fight infectious disease, such as tuberculosis and seasonal flu? The majority of participants did not have vitamin D deficiency at the start of the study. The authors found that when comparing the women with the highest intakes of vitamin D from supplements with women with the lowest intakes, there was a 13% lower risk of developing T2DM. A meta-analysis of 51 clinical trials did not demonstrate that vitamin D supplementation lowered the risk of heart attack, stroke, or deaths from cardiovascular disease. However, taking vitamin D supplements has not been found to reduce cardiovascular risk.
Those who had the lowest levels of vitamin D were twice as likely to have a heart attack as men who had the highest levels. The vitamin also helps to keep arteries flexible and relaxed, which in turn helps to control high blood pressure. A large clinical trial called the VITamin D and OmegA-3 TriaL (VITAL) followed 25,871 men and women 50+ years of age free of any cancers at the start of the study who took either a 2,000 IU vitamin D supplement or placebo daily for a median of five years. The Women’s Health Initiative trial, which followed roughly 36,000 women for an average of seven years, failed to find any reduction in colon or breast cancer risk in women who received daily supplements of 400 IU of vitamin D and 1,000 mg of calcium, compared with those who received a placebo. Animal and laboratory studies have found that vitamin D can inhibit the development of tumors and slow the growth of existing tumors including those from the breast, ovary, colon, prostate, and brain. Many scientific hypotheses about vitamin D and disease stem from studies that have compared solar radiation and disease rates in different countries.

Gender: Female

Social links